Skip to main content

KONINKLIJKE PHILIPS NV

corporate_fare Company Profile

KONINKLIJKE PHILIPS NV

PHG·NYSE·Life Sciences·CIK 0000313216

Koninklijke Philips N.V. is a health technology company operating in North America, Greater China, and internationally. The company is structured into three main segments: Diagnosis & Treatment, Connected Care, and Personal Health. Within its Diagnosis & Treatment segment, Philips provides diagnostic imaging solutions, which include its ultrasound business unit, magnetic resonance imaging (MRI), computed tomography (CT), and diagnostic x-ray systems. This segment also encompasses Image Guided Therapy, offering both image guided therapy systems and image guided therapy devices. The Connected Care segment provides monitoring, enterprise informatics, and sleep and respiratory care solutions. Additionally, the Personal Health segment offers various personal health products. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands. The company changed its name from Koninklijke Philips Electronics N.V. to Koninklijke Philips N.V. in May 2013.

KONINKLIJKE PHILIPS NV (NYSE:PHG) is a publicly traded company in the Life Sciences sector. Wiseek monitors PHG SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Philips Forms Landmark 7-Year Strategic Alliance with WellSpan Health for Imaging and AI Co-Development
  • Philips Finalizes 2025 Dividend with 2% Share Dilution
  • FDA Clears Philips' AI-Powered Elevate Plus Ultrasound, Boosting Diagnostic Efficiency
  • Philips-led Consortium Wins 8-Year Stockholm Hospital-at-Home Contract for 15,000 Patients Annually
  • Philips Reports Strong Q1 2026 Results with 6% Order Growth and Reaffirms Full-Year Outlook

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
€17.83B EUR
Net Income
€897M EUR
Diluted EPS
€0.93 EUR
Gross Profit
€8.06B EUR
Operating Income
€1.42B EUR
Cash & Equivalents
€2.79B EUR
Total Debt
€8.03B EUR
Debt / Equity
0.73×
Net Margin
5.0%
Source: 20-F · filed 2026-02-19 · accession 0001628280-26-009470

Insider Transactions

PHG files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with P →
$26.46
52-week range · as of 2026-06-02 $21.95 – $33.44
Market cap
$25.67B
Volume
1M (0.8× avg)
3-mo avg 1.3M
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PHG - Latest Insights

PHG
Jun 04, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Philips Forms Landmark 7-Year Strategic Alliance with WellSpan Health for Imaging and AI Co-Development
Price at Filing: $25.35
Real-time Price: $26.46 info
Change: +$1.11 (+4%) info
Market Cap: $25.665B info
Sentiment: Positive
View Wiseek Article
PHG
Jun 02, 2026, 9:23 AM EDT
Filing Type: 6-K
Importance Score:
7
Philips Finalizes 2025 Dividend with 2% Share Dilution
Price at Filing: $25.68
Real-time Price: $26.46 info
Change: +$0.780 (+3%) info
Market Cap: $25.665B info
Sentiment: Neutral
View Wiseek Article
PHG
Jun 02, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
FDA Clears Philips' AI-Powered Elevate Plus Ultrasound, Boosting Diagnostic Efficiency
Price at Filing: $25.68
Real-time Price: $26.46 info
Change: +$0.780 (+3%) info
Market Cap: $25.665B info
Sentiment: Positive
View Wiseek Article
PHG
May 18, 2026, 4:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Philips-led Consortium Wins 8-Year Stockholm Hospital-at-Home Contract for 15,000 Patients Annually
Price at Filing: $25.28
Real-time Price: $26.46 info
Change: +$1.18 (+5%) info
Market Cap: $25.665B info
Sentiment: Positive
View Wiseek Article
PHG
May 06, 2026, 9:01 AM EDT
Filing Type: 6-K
Importance Score:
8
Philips Reports Strong Q1 2026 Results with 6% Order Growth and Reaffirms Full-Year Outlook
Price at Filing: $26.99
Real-time Price: $26.46 info
Change: -$0.530 (-2%) info
Market Cap: $25.665B info
Sentiment: Positive
View Wiseek Article
PHG
May 06, 2026, 1:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Philips Posts Strong Q1 with 6% Order Growth, Margin Expansion; Reaffirms 2026 Outlook
Price at Filing: $26.69
Real-time Price: $26.46 info
Change: -$0.230 (-0.86%) info
Market Cap: $25.665B info
Sentiment: Positive
View Wiseek Article
PHG
Feb 19, 2026, 6:40 AM EST
Filing Type: 20-F
Importance Score:
9
Philips Reports Strong 2025 Financial Turnaround and Positive Outlook Amid Significant, Unquantified Legal Risks
Price at Filing: $31.31
Real-time Price: $26.46 info
Change: -$4.85 (-15%) info
Market Cap: $25.665B info
Sentiment: Neutral
View Wiseek Article
PHG
Feb 19, 2026, 6:37 AM EST
Filing Type: 6-K
Importance Score:
8
Philips Reports Strong 2025 Financial Turnaround, Issues Positive 2026 Outlook and Mid-Term Targets
Price at Filing: $31.31
Real-time Price: $26.46 info
Change: -$4.85 (-15%) info
Market Cap: $25.665B info
Sentiment: Positive
View Wiseek Article
PHG
Feb 10, 2026, 7:58 AM EST
Filing Type: 6-K
Importance Score:
8
Philips Proposes Re-appointment of CEO Roy Jakobs Amid Strong Performance and Strategic Outlook
Price at Filing: $31.91
Real-time Price: $26.46 info
Change: -$5.45 (-17%) info
Market Cap: $25.665B info
Sentiment: Positive
View Wiseek Article
PHG
Feb 10, 2026, 7:34 AM EST
Filing Type: 6-K
Importance Score:
9
Philips Reports Strong Q4 & FY25 Results, Announces Positive 2026 Outlook and Mid-Term Growth Targets
Price at Filing: $31.91
Real-time Price: $26.46 info
Change: -$5.45 (-17%) info
Market Cap: $25.665B info
Sentiment: Positive
View Wiseek Article